🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07217327
Recruiting Observational

The DistaSense VITALS Study

NCT07217327 · tracked via the Priya Life Science USA tracker
Sponsor
Life Detection Technologies
Phase
Observational
Started
2025-08-13
Last updated
2025-11-03

Condition(s) studied

Detection of Heart Rate and Respiratory Rate

Investigational drug(s) / intervention(s)

DistaSense and Polysomnography

DistaSense and Polysomnography: All subjects will be evaluated by DistaSense and reference device for respiratory rate and heart rate.

Study summary

A prospective, non-significant risk study designed to validate the performance of the DistaSense Contactless Sensor and algorithm for detecting heart rate and respiratory rate, compared to gold standard reference technology.

Eligibility

Sex
ALL
Min age
22 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: 1. Age ≥ 22 years 2. Fluent in English 3. Willing and cognitively able to provide informed consent 4. BMI \< 36 5. Expected by the investigator to achieve sufficient sleep duration for a minimum of 4 hours of meaningful data (e.g., absence of significant insomnia) 6. Able to complete the scripted portion of the evaluation Exclusion Criteria: 1. Pregnant 2. Sufficiently broken, damaged or irritated skin or rashes near the sensor application sites such that investigator believes should be precluded from enrollment 3. Subjects with electronic implants of any kind (e.g. pacemaker) 4. Subjects that are Life Detection Technology employees or shareholders, or family of a Life Detection Technology employee or shareholder

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Clayton Sleep Institute St Louis Missouri Recruiting
CTI Clinical Research Center Cincinnati Ohio Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07217327 on ClinicalTrials.gov ↗ ← All trials in the USA